CRISPR Therapeutics (CRSP)
55.79
-0.70 (1.24%)
Upcoming Events
Latest Headlines
Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
September 1, 2026 9:07 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
August 31, 2026 6:51 AM - StreetInsider
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens on CTX310 Data
August 31, 2026 5:02 AM - StreetInsider
CRISPR Therapeutics reports one-year CTX310 lipid-lowering data
August 28, 2026 10:31 AM - StreetInsider
CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026
August 28, 2026 10:31 AM - Globe NewsWire
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens
August 25, 2026 4:11 AM - StreetInsider
Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: ORBIS INVESTMENT MANAGEMENT LTD
August 14, 2026 1:28 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Aug 07 Filed by: Prasad Raju
August 11, 2026 5:36 PM - SEC Filing
Agomab proposes two new board members ahead of shareholder vote
August 10, 2026 4:08 PM - StreetInsider
Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
August 10, 2026 4:08 PM - StreetInsider
Agomab proposes two new board members ahead of shareholder vote
August 10, 2026 4:07 PM - StreetInsider
Form 10-Q CRISPR Therapeutics AG For: Jun 30
August 3, 2026 4:32 PM - SEC Filing
CRISPR Therapeutics (CRSP) Tops Q2 EPS by 26c
August 3, 2026 4:26 PM - StreetInsider
Form 8-K CRISPR Therapeutics AG For: Aug 03
August 3, 2026 4:25 PM - SEC Filing
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
August 3, 2026 4:15 PM - Globe NewsWire
Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: BlackRock, Inc.
July 27, 2026 4:26 PM - SEC Filing
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens Ahead of Key Data
July 22, 2026 4:13 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
July 8, 2026 6:41 AM - StreetInsider
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens
July 6, 2026 4:52 AM - StreetInsider
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens
June 12, 2026 4:11 AM - StreetInsider
Morgan Stanley Assumes CRISPR Therapeutics (CRSP) at Equalweight
June 11, 2026 4:23 AM - StreetInsider
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: George Simeon
June 9, 2026 6:09 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Behbahani Ali
June 9, 2026 6:06 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Fardis Maria
June 9, 2026 5:44 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Fleming Harold Edward
June 9, 2026 5:43 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Greene John
June 9, 2026 5:43 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: High Katherine A
June 9, 2026 5:42 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Mahatme Sandesh
June 9, 2026 5:42 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Morrison Briggs
June 9, 2026 5:41 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Rommel Christian
June 9, 2026 5:41 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Jun 05 Filed by: Treco Douglas A
June 9, 2026 5:40 PM - SEC Filing
Full Article List
